The data obtained in our study indicate a connection between increased expression of the inflammation markers CCL2 and miR-155, the hypoxia marker HIF1a, and the appearance of metabolic syndrome components, in particular those of carbohydrate and lipid metabolism disorders (dyslipidemia, dysglycemia). Here, CCL2 is linked to metabolic syndrome.